FDA's Reviews of Prilosec and Nexium: No Heart Attack Risk Increase

Armen Hareyan's picture

On May 29, 2007 AstraZeneca, the maker of Prilosec (omeprazole) and Nexium (esomeprazole), sent FDA data from two long-term studies in patients with severe gastroesophageal reflux disease (GERD) that were being treated with either Prilosec or Nexium.

Share this content.

If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.